DocGo Inc. (NASDAQ:DCGO - Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $5.62 and last traded at $5.60, with a volume of 89921 shares traded. The stock had previously closed at $5.54.
Analysts Set New Price Targets
Separately, Needham & Company LLC reiterated a "buy" rating and issued a $7.00 target price on shares of DocGo in a research report on Thursday, January 16th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $6.10.
Get Our Latest Report on DocGo
DocGo Stock Down 4.8 %
The firm has a market capitalization of $488.82 million, a P/E ratio of 17.11, a PEG ratio of 15.51 and a beta of 1.00. The business's 50-day simple moving average is $4.63 and its 200 day simple moving average is $3.99.
Insider Buying and Selling
In other DocGo news, General Counsel Ely D. Tendler sold 23,088 shares of the company's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the sale, the general counsel now directly owns 175,645 shares in the company, valued at $779,863.80. This represents a 11.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 2.70% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On DocGo
A number of large investors have recently bought and sold shares of the stock. Centiva Capital LP bought a new position in shares of DocGo in the third quarter worth approximately $43,000. Summit Investment Advisors Inc. boosted its position in DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock valued at $45,000 after buying an additional 2,968 shares during the period. Prudential Financial Inc. bought a new position in shares of DocGo during the fourth quarter valued at about $55,000. Intech Investment Management LLC purchased a new stake in shares of DocGo during the third quarter worth about $62,000. Finally, Royce & Associates LP bought a new stake in shares of DocGo in the fourth quarter worth about $64,000. 56.44% of the stock is owned by hedge funds and other institutional investors.
DocGo Company Profile
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Read More
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
